Materias dentro de su búsqueda.
Mostrando 2,521 - 2,540 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 1.00s Limitar resultados
  1. 2521
    “…We assessed the availability of the pancreatic cancer TCGA data (TCGA_PAAD) from several repositories and investigated the nature of each sample and how non-PDAC samples impact prognostic biomarker studies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA Dataset
  2. 2522
    “…While significant advances have been made in the treatment of many different solid tumors, pancreatic cancer remains a glaring exception. Overall 5-year survival rates for pancreatic cancer remain in the single digits. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Advances in Translational Research and Clinical Care in Pancreatic Cancer: Where Are We Headed?
  3. 2523
    “…The tumor distribution patterns in metastatic LNs are the postoperative prognostic factors in pancreatic cancer.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer
  4. 2524
    por Yang, Shufang, Zhang, Heping, Ren, Xuequn
    Publicado 2017
    “…Pancreatic cancer is the fourth leading cause of cancer death in the world. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The application of high-field magnetic resonance perfusion imaging in the diagnosis of pancreatic cancer
  5. 2525
    “…Pancreatic cancer, mostly pancreatic ductal adenocarcinomas (PDAC), is one of the most lethal cancers, with a dismal median survival around 8 months. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer
  6. 2526
    “…Pancreatic cancer has an overall 5-year survival rate of only 9%, due to its rapid metastasis and poor prognosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    P21 activated kinase 2 promotes pancreatic cancer growth and metastasis
  7. 2527
    “…The combination of fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) is the standard of care for advanced pancreatic cancer, but causes hematological and gastrointestinal toxicities, leading to treatment delay and dose reduction; optimal modification based on toxicities is needed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Influence of initial dose intensity on efficacy of FOLFIRINOX in patients with advanced pancreatic cancer
  8. 2528
    por Lu, Yanmin, Wu, Xinqing, Wang, Jinxiang
    Publicado 2019
    “…The aim of this study was to detect the levels of miR-425-5p and IL-23 in tissues of pancreatic cancer patients and to explore their effects on pancreatic cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Correlation of miR-425-5p and IL-23 with pancreatic cancer
  9. 2529
    “…Gemcitabine-based chemotherapy is the first-line treatment for pancreatic cancer. However, chemoresistance is a major obstacle to drug efficacy, leading to poor prognosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway
  10. 2530
    “…Conclusion: The density of TAMs has an impact on the overall survival of pancreatic cancer patients. M2-TAMs can be recognized as a prognostic indicator in pancreatic cancer, which may serve as a potential therapeutic target in the treatment of pancreatic cancer.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysis
  11. 2531
    “…This suggests that the combination therapy of LW6 plus gemcitabine may be a novel therapeutic strategy for pancreatic cancer patients.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LW6 enhances chemosensitivity to gemcitabine and inhibits autophagic flux in pancreatic cancer
  12. 2532
    por Kim, Seong Hun, Lee, Seung Ok
    Publicado 2019
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Developing Consilience Medicine: Positron Emission Tomography Scan and Transcriptomics in Pancreatic Cancer
  13. 2533
    “…PURPOSE: Irreversible electroporation (IRE) has been demonstrated to be a safe and effective method for locally advanced pancreatic cancer (LAPC). The aim of this study was to evaluate the immunomodulatory effect after IRE and to evaluate the prognostic value of variations of the immune parameters in LAPC patients after IRE. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer
  14. 2534
    “…Identification of these hub genes may be considered as potential novel treatment targets for dasatinib-resistance in pancreatic cancer.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Identification of biomarkers and their functions in dasatinib-resistant pancreatic cancer using bioinformatics analysis
  15. 2535
    “…METHODS: This is a retrospective cohort study of pancreatic cancer patients treated between January 2001 and December 2015 in a single academic comprehensive cancer center. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System
  16. 2536
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)
  17. 2537
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immune cell score in pancreatic cancer—comparison of hotspot and whole-section techniques
  18. 2538
    “…METHODS: In eight patients with pancreatic cancer undergoing pancreaticoduodenectomy, primed continuous infusions with L‐[ring‐(13)C(6)]phenylalanine and L‐[3,5‐(2)H(2)]tyrosine were started prior to surgery and continued throughout the surgical procedures. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Tumour‐specific and organ‐specific protein synthesis rates in patients with pancreatic cancer
  19. 2539
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Subacute cutaneous lupus erythematosus induced by gemcitabine in 2 patients with pancreatic cancer
  20. 2540
    “…We share two case reports of patients with pancreatic cancer who developed severe pulmonary toxicity during gemcitabine combination chemotherapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Spectrum of Pulmonary Toxicity in Pancreatic Cancer Patients Receiving Gemcitabine Combination Chemotherapy
Herramientas de búsqueda: RSS